Cocrystal Pharma Q4 EPS $(0.44) Beats $(0.60) Estimate
Cocrystal Pharma, Inc. +2.14% Post
Cocrystal Pharma, Inc.
COCP
|
1.67
1.67
|
+2.14%
0.00% Post |
Cocrystal Pharma (NASDAQ:
COCP) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.60) by 26.67 percent. This is a 18.52 percent increase over losses of $(0.54) per share from the same period last year.